Kidney Cancer Canada Ups Benchstrength Adding Accomplished Health Care professionals to Board
MEDIA RELEASE
Ottawa, Ontario, April 23, 2017 – Kidney Cancer Canada elected Dr. Anil Kapoor, MD, FRCSC and Dr. Mona Sabharwal, Pharm.D. to its Board of Directors today, bringing significant experience and expertise to the organisation’s leadership.
A leading uro-oncologist, Dr. Kapoor is the current head of the Genito-Unrinary program at the Juravinski Cancer Centre, Program Director of the McMaster University Residency Program and Surgical Director of the St. Joseph’s Hospital Transplant Program. A prominent Canadian researcher, he is advancing kidney cancer treatment by providing real-world evidence on the effectiveness of new drugs and combination therapies. He is extensively published and is the current Co-Chair of the NCIC Kidney Cancer Disease Group. He also plays a leadership role in The Kidney Cancer Research Network of Canada and recently served as the Chair of Kidney Cancer Canada’s Medical Advisory Board.
Dr. Sabharwal brings over 20 years of experience in health care, as a registered pharmacist working in both community and hospital practice, as well as program and policy development. Dr. Sabharwal was the inaugural Executive Director of the pan-Canadian Oncology Drug Review (pCODR) where she oversaw the successful launch and operation of a new national initiative which continues to directly impact patients’ access to new cancer medications in Canada. Prior to pCODR, Dr. Sabharwal was involved in drug technology assessment and formulary management for the British Columbia and Ontario governments. Currently, Dr. Sabharwal is the Vice President of Regulatory and Industry Affairs at Rexall.
“We are thrilled by these two new and accomplished additions to our board,” said Andrew Weller, Board Chair, Kidney Cancer Canada. “Dr. Kapoor brings first-hand knowledge of the importance of providing patients with the most current advances in kidney cancer treatment. Dr. Sabharwal has a deep understanding of the system that ensure patients have access to them.
“Together we will be even stronger in our commitment to making a difference for people living with kidney cancer.”
About Kidney Cancer Canada
Kidney Cancer Canada is the only Canadian-based, patient-led registered charity committed to improving the quality of life for patients and their families living with kidney cancer. Kidney Cancer Canada advocates for access to new treatments, provides support and information to patients, and works to increase awareness of kidney cancer as a significant health issue. Kidney Cancer canada also supports the Kidney Cancer Research Network of Canada.
In 2017, more than 6,000 Canadians will be diagnosed with kidney cancer and more than 1,800 will die from the disease. Visit kcc-forum.eproofs.ca for more information.
-30-
For more information or to arrange an interview with Dr. Kapoor or Dr. Sabharwal, please contact:
Mona Awad, Bilingual Communications Specialist
Kidney Cancer Canada
514 907-2188 or 1-866-598-7166 – Extension 7
mawad@kidneycancercanada.ca
